TABLE 4.
An overview of recent data on COVID‐19 and its impact on patients with malignancies
| Authors | Year | Country | Population | ICU admission | Mortality rate |
|---|---|---|---|---|---|
| Guan et al. 14 | 2019 | China |
Non‐cancer (1089) Cancer (10) |
4.8% 30% |
1.4% 0 |
| Huang et al. 15 | 2020 | China |
Non‐cancer (40) Cancer (1) |
31.7% 0 |
15% 0 |
| Yang et al. 16 | 2020 | China |
Non‐cancer (50) Cancer (2) |
100% 100% |
62% 50% |
| Wang et al. 17 | 2020 | China |
Non‐cancer (128) Cancer (10) |
25% 40% |
— |
| Lei et al. 18 | 2020 | China |
Non‐cancer (25) Cancer (9) |
40% 55.5% |
12% 44.4% |
| Lee et al. 19 | 2020 | UK | Cancer (1044) | — | 28.2% |
| Erdal et al. 13 | 2021 | Turkey |
Non‐cancer (4412) Cancer (77) |
— |
1.51% 23.9% |
| Present study | 2020 | Iran |
Non‐cancer (93) Cancer (92) |
15.1% 24.7% |
17.2% 41.3% |